A study has identified a gene expression profile associated with an elevated risk of cardiovascular death. Combined with other indicators such as biochemical markers and family history, a simple blood test may identify patients who could benefit from early treatment and counseling to reduce their heart attack risk. Senior author Dr. Gregory Gibson explains, “We envision that with our gene expression-based marker, plus some biochemical markers, genotype information and family history, we could produce a tiered evaluation of people’s risks of adverse coronary events.”
Genome Medicine, May 2014